Real-world outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) who received first- or second-line immunotherapies (IO) in the United States (US).

 Article Details
Title: Real-world outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) who received first- or second-line immunotherapies (IO) in the United States (US).
Dateline: 2020-02-13    DisplayDateline   
Byline: Boyd M, Annavarapu S, Doshi GK, Imai K, Sbar E, Godwin JL, Li H, Sonpavde G
Publication Title: ASCO GU  
CTA Link: https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.6_suppl.457
CTA Text: Read More
Filter(s):*
This creates the tags that filter the listing page by specific taxonomies that display to the right of the main content and read more link.
 
 

top